Dermatologic Common (1% to 10%): Hair loss, rash, urticaria Postmarketing reports : Alopecia, angioedema, rash, urticaria Hair loss was reported in up to 5.8% of treated patients vs 1% placebo, with higher incidence associated with greater weight loss (20% or more)
Semaglutide is a scientifically advanced, FDA-approved treatment that offers real metabolic transformation not just a temporary fix
The format flexibility is rare, but Henry holds a BBB F rating, uses contractual obligation language on canceled accounts, and locks patients into a 6-to-12-month prepay, which disqualified it from the no-membership shortlist
On average, patients lose 515% of body weight over several months
Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drugs manufacturer
Other Possible Side Effects: Fatigue : General feeling of tiredness or low energy